Approvals/CIMA-AEMPS/EBVALLO 2,8 × 10E7 - 7,3 × 10E7 CÉLULAS /ML DISPERSION INYECTABLE

Approved

STANDARD

EBVALLO 2,8 × 10E7 - 7,3 × 10E7 CÉLULAS /ML DISPERSION INYECTABLE

Pierre Fabre Medicament🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: c919fa2794d4af13
Drug Cima Aemps Name: EBVALLO 2,8 × 10E7 - 7,3 × 10E7 CÉLULAS /ML DISPERSION INYECTABLE
Register Number: 1221700001
Holder Company Name: Pierre Fabre Medicament
Marketing Company Name: Pierre Fabre Iberica S.A.
Holder Company Detail Path: /organization/pierre-fabre-medicament
Authorization Date: 2023-01-12
Dosage Form: DISPERSIÓN INYECTABLE
Dose: 2,8×10e7 - 7.3×10e7 celulas/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Pierre Fabre Medicament
Company Detail Path: /organization/pierre-fabre-medicament

TABELECLEUCEL

5 x 10E7 células/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 12, 2023

Approval ID

c919fa2794d4af13

Type

Standard